Current Liabilities decreased faster than Cg Oncology Inc 's Cash & cash equivalent, this led to improvement in Cg Oncology Inc 's Quick Ratio to 100.74, above Cg Oncology Inc average Quick Ratio.

Within Biotechnology & Pharmaceuticals industry 9 other companies have achieved higher Quick Ratio than Cg Oncology Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 82 to 200.

Explain Quick Ratio?
How much Cash & cash equivalents CGON�s has?
What are CGON�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/CGON/financial-strength

https://api.csimarket.com/api/v1/companies/CGON/fundamentals

https://api.csimarket.com/api/v1/companies/CGON/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

CGON Quick Ratio	(Sep 30 2026) Q3	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3
Y / Y Current Liabilities Change	-67.99 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	44.72 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	100.74	Subscribe	Subscribe	Subscribe	Subscribe
CGON's Total Ranking	# 200	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	-79.31 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	-4.26 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 10
Healthcare Sector	# 47
Overall Market	# 200

Quick Ratio Statistics
High	Average	Low
56.74	30.58	12.78
(Mar 31 2024)		(Dec 31 2023)

Financial Statements
Cg Oncology Inc 's Current Liabilities	$ 10 Millions	Visit CGON's Balance sheet
Cg Oncology Inc 's Cash & cash equivalent	$ 984 Millions	Visit CGON's Balance sheet
Source of CGON's Sales		Visit CGON's Sales by Geography

Cumulative Cg Oncology Inc 's Quick Ratio

CGON's Quick Ratio for the trailling 12 Months

CGON Quick Ratio	(Sep 30 2026) 12 Months	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	17.29 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	38.22 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	31.13	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 3969	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	-14.43 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	8.62 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to CGON Financial Strength Comparisons >> Go to Compare CGON Quick Ratio to its Competitors

On the trailing twelve months basis CGON Cash & cash equivalent soared by 44.72 % in Q3 2026 year on year, while Current Liabilities dropped to $10 millions, this led to increase in in Cg Oncology Inc 's Quick Ratio to 31.13, above CGON average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 141 other companies have achieved higher Quick Ratio than Cg Oncology Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 2080 to 3969.

Explain Quick Ratio?
How much Cash & cash equivalents CGON�s has?
What are CGON�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Biotechnology & Pharmaceuticals Industry	# 142
Healthcare Sector	# 896
Within the Market	# 3969

trailing twelve months Quick Ratio Statistics
High	Average	Low
6.85	3.2	0.91
(Dec 31 2024)		(Jun 30 2026)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Biotechnology & Pharmaceuticals Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Cg Oncology Inc	100.74	$ 984.458 Millions	$ 9.772 Millions
Hemab Therapeutics Holdings Inc	33.25	$ 430.238 Millions	$ 12.940 Millions

Date modified: 2026-11-09T18:44:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.